At Amplion, we are driven by our passion for improving patient outcomes through precision medicine. The Amplion Intelligence Platform leverages proprietary machine learning and expert annotation to provide evidence-based insights for the key strategic decisioning life science teams need to be successful in the emerging world of precision medicine. We look forward to helping you achieve your mission.
By harnessing the world’s largest and fastest-growing corpus of biomedical evidence, the company’s solutions deliver timely, targeted, and actionable insights to enable confident strategic decisions in drug and diagnostic development.
Total Funding: $2,625,000
Funding Stage: Series A
Business Stage: Scaling Up
Market: B2B
Company Size: 26 to 50
Founded: 2013
